Robert Burns

Robert Burns

Direttore/Membro del Consiglio presso CIRCIO HOLDING ASA
79 anni
Health Technology
Commercial Services
Industrial Services

Profilo

Dr. Robert F.
Burns is an Independent Director at Circio Holding ASA and a Chairman at Affibody Medical AB. He is on the Board of Directors at Circio Holding ASA. Dr. Burns was previously employed as a President & Chief Executive Officer by Affitech A/S, a Chairman by Haemostatix Ltd., a President & Chief Executive Officer by Celldex Therapeutics, Inc. (Old), a Chief Executive Officer by 4-Antibody AG, a Principal by ABT Corp, a Principal by Applied Biotech, Inc., a Chief Executive Officer by Celldex Therapeutics, Inc., a Principal by Ligand UK Ltd., a Director-Technology Licensing by Ludwig Institute for Cancer Research Ltd., a Principal by Ogs SA, a Principal by Oxford GlycoSciences Plc, and a Principal by Piramed Ltd. He also served on the board at Targovax Oy.
He received his doctorate degree from the University of Birmingham.

Posizioni attive di Robert Burns

SocietàPosizioneInizio
CIRCIO HOLDING ASA Direttore/Membro del Consiglio 01/07/2015
Presidente -

Precedenti posizioni note di Robert Burns

SocietàPosizioneFine
Amministratore Delegato 01/10/2008
Direttore/Membro del Consiglio -
Amministratore Delegato -
Amministratore Delegato -
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Robert Burns

Formazione di Robert Burns

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

23

Relazioni di 1° grado

16

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private16

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Industrial Services

Health Technology

Technology Services

Consumer Services

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Robert Burns
- 40%: I migliori strumenti riservati agli abbonati per individuare le opportunità di investimento di domani.
g
:
:
ENTRA ORA